HTHiromu Tanaka

Hiromu Tanaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiromu Tanaka has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current Terminal Care for Cancer Patients and Significance of Palliative Care Units

    by Hiromu Tanaka, Yuki Eguchi, Akiko Matsumoto, Kensuke Sugii, Tomoka Sakaguchi, Yukari Tango, Tsutomu Maruhama, Tsuneo Yabusako

  • Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.

    by Kazuhisa Kaneda, Shoji Kubo, Hiromu Tanaka, Shigekazu Takemura, Kazuki Ohba, Takahiro Uenishi, Shintaro Kodai, Hiroji Shinkawa, Yorihisa Urata, Masayuki Sakae, et al.

    We investigated the clinicopathological findings and outcome after surgery for hepatocellular carcinoma in patients without hepatitis B or C virus infection. Among 562 patients who underwent curative resection for hepatocellular carcinoma, the sera from 97 patients (B group) were positive for hepatitis B surface antigen alone, sera from 355 patients (C group) were positive for anti-hepatitis C virus antibody alone and sera from 104 patients (NBNC group) were negative for both hepatitis B surface antigen and anti-hepatitis C virus antibody. We compared the clinicopathological findings and postoperative outcomes in the 3 groups. The prevalence of diabetes mellitus, hypertension, hyperlipidemia and alcohol abuse were higher in the NBNC group than in the other groups. The prevalence of obesity was higher in the NBNC group than in the B group. Non-alcoholic steatohepatitis was detected in 16 NBNC patients. The tumor- free survival rate was higher in the NBNC group than in the C group. Obesity, diabetes mellitus, hypertension, hyperlipidemia, alcohol abuse and non-alcoholic steatohepatitis were the possible risk factors for hepatocellular carcinoma in the NBNC group. The patients in the NBNC group are expected to show a better outcome as compared to patients in the C group.


    • 30 May 2008
      • Vol. 55  (81) , 160-3

    Convenience of a tape-guiding technique in different types of hepatectomy.

    by Hiromu Tanaka, Shigekazu Takemura, Kazuki Ohba, Seikan Hai, Tsuyoshi Ichikawa, Shintaro Kodai, Hiroji Shinkawa, Taichi Shuto, Kazuhiro Hirohashi, Shoji Kubo

    The liver hanging maneuver is widely used in right lobectomy to resect huge tumors and harvest living donors. The convenience of tape assistance in other types of hepatectomy is not well known. Tape-guiding technique (TGT) was applied in 30 hepatectomies of different type between April 2003 and April 2006. The indications were liver carcinoma in 22 and living-donor in 8. Hepatectomies included right lobectomy, 14; left lobectomy with caudate lobectomy, 8; left lobectomy without caudate lobectomy, 2; lateral segmentectomy, 3; central bisegmentectomy, posterior segmentectomy, and superior dorsal partial resection, 1 each. A tape was placed in front of the inferior vena cava for right hepatectomy and left hepatectomy with caudate lobectomy. In other hepatectomies, the tape was positioned to be the target of parenchymal dissection. TGT was successfully performed in all 30 cases. Tape facilitated dissection by helping the surgeon maintain orientation, and traction on the tape flattened the parenchyma, making it easier to identify and manage vessels and ducts. With an assistant holding the tape, the surgeon's left hand was free, and ligation and suturing was easier and more secure. The TGT is a convenient technique that is applicable to different types of liver resection.


    • 27 June 2007
      • Vol. 54  (75) , 830-3

    Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis.

    by Shoji Kubo, Shigekazu Takemura, Satoshi Yamamoto, Seikan Hai, Tsuyoshi Ichikawa, Shintaro Kodai, Shinkawa Hiroji, Taichi Shuto, Kazuhiro Hirohashi, Hiromu Tanaka

    Liver resection for hepatocellular carcinoma in patients with cirrhosis carries risk of major hemorrhage and sometimes requires blood transfusion. We investigated risk factors for massive blood loss during liver resection and indications for storing blood for autologous intraoperative transfusion. We analyzed clinical records of 100 patients with cirrhosis who underwent liver resection for hepatocellular carcinoma. Autologous blood was stored preoperatively for 19 patients. Intraoperative blood loss ranged from 5 to 3000 mL (mean, 640). Liver resection was performed without transfusion in 67 patients and with autologous blood storage in 17 patients not receiving homologous blood. In the other 16 patients, homologous blood was transfused. Univariate analysis identified youth, large tumors (> 4cm), major hepatectomy, portal tumor involvement, hepatic vein involvement, and prolonged operation time as risk factors for massive blood loss; multivariate analysis identified portal involvement and hepatic vein involvement as independent risk factors. Blood loss exceeded 1000 mL in the 4 transfused group B patients and 3 of the 4 patients had hepatic vein involvement. Portal involvement and hepatic vein involvement were risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. Autologous blood storage is indicated in patients with such risk factors.


    • 1 December 2006
      • Vol. 52  (2) , 79-82

    Splenic metastasis of hepatocellular carcinoma.

    by Hiroaki Hayashi, Shogo Tanaka, Taichi Shuto, Hiromu Tanaka, Tsuyoshi Ichikawa, Takatsugu Yamamoto, Shigekazu Takemura, Kazuhiro Hirohashi, Shoji Kubo

    A 76-year-old man, who underwent central bisegmentectomy of the liver, transcatheter arterial chemoembolization, and radiofrequency ablation for chronic hepatitis C virus-related hepatocellular carcinoma (HCC), was found to have a 3 cm mass in the spleen and a 2 cm mass in the liver by computed tomography in January 2003. As both tumors were adjacent, a diagnosis of HCC with splenic infiltration was made. In February 2003, transcatheter arterial chemoembolization and splenic arterial chemo-infusion were performed. However, the splenic tumor increased to 5 cm with slight enhancement on contrast-enhanced computed tomography performed 6 months later, while the hepatic tumor had no enhancement. Limited resection of the liver with splenectomy was performed in October 2003. Macroscopically, the splenic tumor showed infiltrative growth without a capsule while the hepatic tumor showed complete necrosis within its capsule. The splenic tumor was limited to the splenic parenchyma. Histologic examination revealed that the splenic tumor was poorly differentiated HCC, leading to the diagnosis of splenic metastasis. The patient is doing well 17 months after surgery without recurrence. One should perform surgery for splenic metastasis of HCC without hesitation whenever possible.


    • 26 September 2006
      • Vol. 53  (70) , 571-5

    Bowel injury associated with liver surgery for hepatocellular carcinoma.

    by Shogo Tanaka, Hiromu Tanaka, Shoji Kubo, Taichi Shuto, Shigekazu Takemura, Takatsugu Yamamoto, Takahiro Uenishi, Seikan Hai, Harushi Osugi, Kazuhiro Hirohashi

    Bowel injury associated liver surgery is rare but can be fatal if not adequately treated. The contribution of underlying liver disease and previous hepatectomy to bowel injury in hepatectomy for hepatocellular carcinoma is unknown. Clinical records of 531 patients who underwent hepatic resection without combined resection of the biliary tract or intestine for hepatocellular carcinoma during 13 years were reviewed. Differences in incidence of bowel injury according to presence or absence of liver cirrhosis, technique of hepatectomy, and history of hepatectomy were investigated. Outcome after treatment also was reviewed. Bowel injury occurred in 5 patients (0.9%). Previous hepatectomy history was associated with an increased incidence of bowel injury [repeat hepatectomy, 3/91 (3.3%), and first hepatectomy, 2/440 (0.5%), p = 0.038]. Injury was recognized intraoperatively in two patients and postoperatively in three. In the former two patients, the injured bowel was repaired immediately but a fistula still developed in one patient. One patient with a fistula eventually required temporary fecal diversion and eventually limited colectomy. The other three patients were treated by continuous external drainage, but two of them required debridement or colic sleeve resection. Previous hepatectomy increases the risk for bowel injury during hepatectomy. Care must be taken to prevent adhesion to the hepatic cut surface. Careful use of electrocautery to prevent burn injury also should be taken.


  • Recurrence Rate and Transplantability After Liver Resection in Patients With Hepatocellular Carcinoma Who Initially Met Transplantation Criteria

    by H. Tanaka, S. Kubo, T. Tsukamoto, T. Shuto, S. Takemura, T. Yamamoto, T. Okuda, A. Kanazawa, K. Hirohashi


  • Open Access

    A RESECTED CASE OF ADRENOCORTICAL ADENOMA MIMICKING HEPATOCELLULAR CARCINOMA

    by Shogo Tanaka, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Takatsugu Yamamoto, Shoji Kubo

    症例は53歳,女性.慢性B型肝炎と肝S7腫瘍に対する経過観察中, 2004年12月のCT像上,同腫瘍径が軽度増大した.副腎皮質ホルモン亢進に伴う症状はなく,血液検査上軽度の肝機能障害が認められるのみであった.単純CT像上,径1.6cm大の境界明瞭な低吸収像, dynamic CT早期相において淡く濃染され,晩期相において造影剤はwash outされていた.右肝動脈造影下CTでは腫瘍の大部分は高吸収域として描出された.以上より肝細胞癌と診断,開腹したところ,右副腎は腫瘍と周囲肝実質と強固に癒着していたため,右副腎合併肝部分切除を施行した.腫瘍割面は径1.6cm,黄色調で被膜は認めないものの周囲との境界は明瞭であった.組織学的に腫瘍は副腎と連続性があり肝を圧排していた.脂肪滴を含んだ泡沫状の明るい胞体をもつ淡明型細胞が認められ,副腎腺腫と診断された.肝内に存在するように描出され,肝動脈から栄養されていたため肝細胞癌との術前鑑別が困難であった副腎非機能腺腫例であった.


    • 1 October 2004
      • Vol. 105  (10) , 669-73

    [Hepatic failure after liver resection in patients with cirrhosis].

    by Shoji Kubo, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Takahiro Uenishi, Shogo Tanaka, Kazuhiro Hirohashi

    Despite improvements in the preoperative assessment of liver function and advances in surgical techniques, liver resection for hepatocellular carcinoma still holds a risk for postoperative hepatic failure, especially in patients with cirrhosis. Physiologic characteristics in patients with cirrhosis include hyperdynamic state of the systemic circulation, decrease in hepatic blood flow, portal hypertension, metabolic disorders, dysfunction of the reticuloendothelial system, and thrombocytopenia. Surgical stress including massive bleeding, disturbance of hepatic circulation, and infection are risk factors for postoperative hepatic failure. The risk of hepatic failure also correlates with the severity of active hepatitis and the degree of hepatic fibrosis. To prevent postoperative hepatic failure, dopamine, prostaglandin, and hydrocortisone have been used. Although various treatments including plasma exchange have been tried in hepatic failure, the results have often been unsatisfactory. Careful preoperative evaluation of the hepatic functional reserve and the severity of active hepatitis, and adequate selection of surgical method are important to prevent postoperative hepatic failure.

    • 15 September 2004
      • Vol. 51  (59) , 1292-4

    Curative resection of a huge bile duct cancer without pancreatoduodenectomy.

    by Shogo Tanaka, Kazuhiro Hirohashi, Shoji Kubo, Takatsugu Yamamoto, Takahiro Uenishi, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Masao Ogawa, Keiichi Yamasaki, et al.

    A 71-year-old woman was admitted to our hospital with obstructive jaundice. Magnetic resonance cholangiography revealed a 9-cm spindle-shaped tumor in the common bile duct. Laboratory examination noted a high concentration of total serum bilirubin. Although the serum concentration of carcinoembryonic antigen was within normal limits, the serum concentration of carbohydrate antigen 19-9 was elevated. We diagnosed the lesion as an extrahepatic bile duct cancer and performed a laparotomy. The anterior wall of the common bile duct was incised, and the tumor was found to have a small base in only the posterior wall of the duct, and spread within the duct was from the common hepatic duct to the intrapancreatic bile duct. Bile duct resection, cholecystectomy with lymphadenectomy and hepaticojejunostomy were performed. Frozen sections of the proximal and distal surgical margins of the bile duct were free of cancer. Macroscopically, the lesion was an expansive polypoid tumor measuring 9x3cm in diameter arising from a 5-mm base. Histologic examination revealed that the tumor was a well-differentiated tubular adenocarcinoma that had infiltrated the fibromuscular layer at its base. Longitudinal spread was more extensive hepatopetally than hepatofugally. The patient is alive and well without any complaints 8 months after surgery.